Ann Shinn Related Content
Dr. Ann K. Shinn offers independent feedback to a new study looking at the gut microbiome differences in adults living with treatment-resistant schizophrenia.
Dr. Ann K. Shinn comments on the findings of a clinical trial examining a new antipsychotic medication.
Ann K. Shinn, MD, MPH , is the 2022 recipient of the Thomas A. McMahon Mentoring Award from the Harvard-MIT Program in Health Sciences and Technology (HST). Shinn is the director of clinical research for McLean Hospital’s Schizophrenia and Bipolar Disorder Research Program . The McMahon Award was...
Dr. Ann K. Shinn and others discuss the differences and similarities between first-generation and second-generation antipsychotics.
Dr. Ann K. Shinn comments on a study that mapped communication between the cerebral cortex and the cerebellum.
Dr. Ann K. Shinn suggests a shift from a reactive approach to psychiatric patient care to a more proactive approach.
Dr. Ann K. Shinn examines the impact of COVID-19 on individuals with serious mental illness, such as schizophrenia and bipolar disorder.
Join us as Ann K. Shinn, MD, MPH , offers a comprehensive look at both schizophrenia and bipolar disorder, provides guidance for recognizing their signs and symptoms, and answers audience questions about effective treatment for these conditions.